Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-18-004303

Options or other derivatives

  • Director acquired 3,850 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lynch Thomas G Director 2018-01-17 Grant or award · Stock Option (right to buy) +3,850 3,850 D
Loading xslF345X03/doc4.xml…